Computational insight into dengue virus NS2B-NS3 protease inhibition: A combined ligand- and structure-based approach

The NS2B-NS3 protease is essential for the replication process of Dengue Virus, which make it an attractive target for anti-virus drugs. Since a considerable number of NS2B-NS3 protease inhibitors have been reported so far, it is significant for the discovery of more effective antivirus compounds with the essential structure-activity relationship extracted from known inhibitors. In this perspective, the relationship between the chemical features of inhibitors and their biological activities was investigated with a combined ligand- and structure-based approach. Furthermore, 3D pharmacophore models were generated with the best selected, which consisted of five chemical features: one ring aromatic group, one hydrophobic group, one hydrogen bond donor and two hydrogen bond acceptors (RHDAA). Subsequently, molecular docking was employed to explore the specific allosteric site for non-peptidic inhibitors to bind, which was proved to be located behind the catalytic triad. Taken the results of both molecular docking and pharmacophore modeling into consideration, a model of receptor-ligand interaction was obtained with four essential chemical features including aromatic rings and hydrogen bonds. This research provided an accurate binding model for the discovery and optimization of NS2B-NS3 protease inhibitors.

[1]  Dennis Normile,et al.  Tropical medicine. Surprising new dengue virus throws a spanner in disease control efforts. , 2013, Science.

[2]  John S. Brownstein,et al.  The global distribution and burden of dengue , 2013, Nature.

[3]  Dahai Luo,et al.  The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development. , 2015, Antiviral research.

[4]  Christoph Nitsche,et al.  Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases. , 2011, Bioorganic & medicinal chemistry.

[5]  Zheng Yin,et al.  Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus , 2006, Nature Structural &Molecular Biology.

[6]  Johan Wouters,et al.  Structural insights into human 5-lipoxygenase inhibition: combined ligand-based and target-based approach. , 2006, Journal of medicinal chemistry.

[7]  Alex Y Strongin,et al.  Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold , 2007, Protein science : a publication of the Protein Society.

[8]  Zhili Zuo,et al.  Discovery of novel small molecule inhibitors of dengue viral NS2B-NS3 protease using virtual screening and scaffold hopping. , 2012, Journal of medicinal chemistry.

[9]  Andrew J Tatem,et al.  Global traffic and disease vector dispersal. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Diana Montes-Grajales,et al.  Discovery of antiviral molecules for dengue: In silico search and biological evaluation. , 2016, European journal of medicinal chemistry.

[11]  Zhili Zuo,et al.  Mechanism of NS2B-Mediated Activation of NS3pro in Dengue Virus: Molecular Dynamics Simulations and Bioassays , 2008, Journal of Virology.

[12]  Puay Hoon Tan,et al.  The pathology of dengue hemorrhagic fever. , 2007, Seminars in diagnostic pathology.

[13]  John M. Fonner,et al.  Identification of a Novel Inhibitor of Dengue Virus Protease through Use of a Virtual Screening Drug Discovery Web Portal , 2014, J. Chem. Inf. Model..

[14]  F. Guirakhoo,et al.  Traditional and novel approaches to flavivirus vaccines. , 2003, International journal for parasitology.

[15]  Martin J. Stoermer,et al.  Structure of West Nile virus NS3 protease: ligand stabilization of the catalytic conformation. , 2009, Journal of molecular biology.

[16]  Mao-Sheng Cheng,et al.  In Silico Design of Human IMPDH Inhibitors Using Pharmacophore Mapping and Molecular Docking Approaches , 2015, Comput. Math. Methods Medicine.

[17]  David Beer,et al.  Ten years of dengue drug discovery: progress and prospects. , 2013, Antiviral research.

[18]  Jing Chen,et al.  Identification of novel thiadiazoloacrylamide analogues as inhibitors of dengue-2 virus NS2B/NS3 protease. , 2014, Bioorganic & medicinal chemistry.

[19]  P. Shi,et al.  Ligand-Bound Structures of the Dengue Virus Protease Reveal the Active Conformation , 2011, Journal of Virology.

[20]  Peter Güntert,et al.  Structure-guided fragment-based in silico drug design of dengue protease inhibitors , 2011, J. Comput. Aided Mol. Des..

[21]  Christoph Nitsche,et al.  Biochemistry and medicinal chemistry of the dengue virus protease. , 2014, Chemical reviews.

[22]  D. Gubler,et al.  Dengue and dengue haemorrhagic fever , 1998, The Lancet.

[23]  Christoph Nitsche,et al.  The Medicinal Chemistry of Dengue Virus. , 2016, Journal of medicinal chemistry.

[24]  Venkatesan Jayaprakash,et al.  Synthesis and molecular modelling studies of novel sulphonamide derivatives as dengue virus 2 protease inhibitors. , 2015, Bioorganic chemistry.

[25]  Punnee Pitisuttithum,et al.  The first licensed dengue vaccine: an important tool for integrated preventive strategies against dengue virus infection , 2016, Expert review of vaccines.

[26]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[27]  P. Yogeeswari,et al.  A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture , 2015, Virology Journal.

[28]  Ralf Bartenschlager,et al.  Novel Dengue Virus NS2B/NS3 Protease Inhibitors , 2014, Antimicrobial Agents and Chemotherapy.

[29]  C. Rice,et al.  Production of yellow fever virus proteins in infected cells: identification of discrete polyprotein species and analysis of cleavage kinetics using region-specific polyclonal antisera. , 1990, Virology.

[30]  Wei Li,et al.  Computational Insight into Protein Tyrosine Phosphatase 1B Inhibition: A Case Study of the Combined Ligand- and Structure-Based Approach , 2017, Comput. Math. Methods Medicine.

[31]  D. Fairlie,et al.  Mutagenesis of the West Nile virus NS2B cofactor domain reveals two regions essential for protease activity. , 2008, The Journal of general virology.

[32]  Eva Harris,et al.  Global spread and persistence of dengue. , 2008, Annual review of microbiology.

[33]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..